Abstract
Examining potential drug–target interactions (DTIs) is a pivotal component of drug discovery and repurposing. Recently, there has been a significant rise in the use of computational techniques to predict DTIs. Nevertheless, previous investigations have predominantly concentrated on assessing either the connections between nodes or the consistency of the network’s topological structure in isolation. Such one-sided approaches could severely hinder the accuracy of DTI predictions. In this study, we propose a novel method called TTGCN, which combines heterogeneous graph convolutional neural networks (GCN) and graph attention networks (GAT) to address the task of DTI prediction. TTGCN employs a two-tiered feature learning strategy, utilizing GAT and residual GCN (R-GCN) to extract drug and target embeddings from the diverse network, respectively. These drug and target embeddings are then fused through a mean-pooling layer. Finally, we employ an inductive matrix completion technique to forecast DTIs while preserving the network’s node connectivity and topological structure. Our approach demonstrates superior performance in terms of area under the curve and area under the precision–recall curve in experimental comparisons, highlighting its significant advantages in predicting DTIs. Furthermore, case studies provide additional evidence of its ability to identify potential DTIs.
Funding Information
  • National Natural Science Foundation of China (Nos.32260225, Nos.32260225, Nos.32260225)
  • Guizhou Provincial Science and Technology Projects ([QIANKEHEJICHU-ZK [2021] Key 038, [QIANKEHEJICHU-ZK [2021] Key 038, [QIANKEHEJICHU-ZK [2021] Key 038)
  • Research Foundtion for Science and Technology Innovation Team of Guizhou Province (QJJ[2023]063)
  • Guizhou Provincial Basic Research Program (QIANKEHEJICHU-ZK [2023] 268)